BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 30633039)

  • 1. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
    Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.
    Zhang H; Xiao J; Tu J; Zhang M; Zhang F; Yin Q; Zhuge Y
    Eur J Gastroenterol Hepatol; 2021 May; 33(5):752-761. PubMed ID: 33731589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization.
    Schultheiß M; Giesler M; Maruschke L; Schmidt A; Sturm L; Thimme R; Rössle M; Bettinger D
    Cardiovasc Intervent Radiol; 2019 May; 42(5):729-736. PubMed ID: 30788517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension.
    Mukhiya G; Han X; Jiao D; Bi Y; Pokhrel G; Liu Z; Li Z; He Y
    Clin Med Res; 2023 Sep; 21(3):144-154. PubMed ID: 37985166
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
    Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
    J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A systematic review and meta-analysis.
    Yang M; Qiu Y; Wang W
    Dig Liver Dis; 2024 Jun; 56(6):978-985. PubMed ID: 37926635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding.
    Tesdal IK; Filser T; Weiss C; Holm E; Dueber C; Jaschke W
    Radiology; 2005 Jul; 236(1):360-7. PubMed ID: 15955858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
    J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Zou X; Xue M; Li J
    Med Sci Monit; 2021 Nov; 27():e934436. PubMed ID: 34840325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
    Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
    Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
    Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.